Ganga Pharma
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
Get instant stock alerts
- Share Price
- Financials
- Revenue mix
- Shareholdings
- Peers
- Forensics
Share Price
Coming soon
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
Financials
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
Revenue mix
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Forensics
Recent events
-
News
-
Corporate Actions
March 10 (Reuters) - Ganga Pharmaceuticals Ltd GNPH.BO:
RE-APPOINTS BHARAT BRIJMOHAN SHARMA AS MANAGING DIRECTOR
Source text: ID:nBSEQSCDl
Further company coverage: GNPH.BO
(([email protected];;))
March 10 (Reuters) - Ganga Pharmaceuticals Ltd GNPH.BO:
RE-APPOINTS BHARAT BRIJMOHAN SHARMA AS MANAGING DIRECTOR
Source text: ID:nBSEQSCDl
Further company coverage: GNPH.BO
(([email protected];;))
Nov 27 (Reuters) - Ganga Pharmaceuticals Ltd GNPH.BO:
TO CONSIDER FUND RAISING
Source text for Eikon: ID:nBSE1s1dpg
Further company coverage: GNPH.BO
(([email protected];))
Nov 27 (Reuters) - Ganga Pharmaceuticals Ltd GNPH.BO:
TO CONSIDER FUND RAISING
Source text for Eikon: ID:nBSE1s1dpg
Further company coverage: GNPH.BO
(([email protected];))
More Nano Cap Ideas
See similar 'Nano' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
- Business
- Financials
- Share Price
- Shareholdings
What does Ganga Pharma do?
Ganga Pharmaceuticals Ltd. is a pharmaceutical company specializing in the manufacturing of ayurvedic products including tablets, pills, balms, creams, syrups, and oils.
Who are the competitors of Ganga Pharma?
Ganga Pharma major competitors are Decipher Labs, Hemo Organic, Senbo Industries, Secunderabad Health., Hind Bio Science, Adline Chem Lab, Zyden Gentec. Market Cap of Ganga Pharma is ₹7 Crs. While the median market cap of its peers are ₹8 Crs.
Is Ganga Pharma financially stable compared to its competitors?
Ganga Pharma seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does Ganga Pharma pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Ganga Pharma latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Ganga Pharma allocated its funds?
Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments, Short Term Loans & Advances
How strong is Ganga Pharma balance sheet?
Balance sheet of Ganga Pharma is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Ganga Pharma improving?
Yes, profit is increasing. The profit of Ganga Pharma is ₹0.08 Crs for Mar 2025, ₹0.05 Crs for Mar 2024 and ₹0.04 Crs for Mar 2023
Is the debt of Ganga Pharma increasing or decreasing?
Yes, The net debt of Ganga Pharma is increasing. Latest net debt of Ganga Pharma is ₹1.03 Crs as of Mar-26. This is greater than Mar-25 when it was ₹0.84 Crs.
Is Ganga Pharma stock expensive?
Ganga Pharma is not expensive. Latest PE of Ganga Pharma is 89.76, while 3 year average PE is 182. Also latest EV/EBITDA of Ganga Pharma is 0 while 3yr average is 19.45.
Has the share price of Ganga Pharma grown faster than its competition?
Ganga Pharma has given better returns compared to its competitors. Ganga Pharma has grown at ~7.75% over the last 9yrs while peers have grown at a median rate of 5.17%
Is the promoter bullish about Ganga Pharma?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Ganga Pharma is 50.91% and last quarter promoter holding is 50.91%.
Are mutual funds buying/selling Ganga Pharma?
There is Insufficient data to gauge this.